Overview

Improved pharmaceuticals using intelligent technologies marks a fundamental shift in how life-changing therapies are conceived and brought to patients. By using predictive modeling and generative algorithms, researchers can identify promising compounds and optimize drug candidates with unprecedented speed and precision. This data analysis approach accelerates early discovery and reduces costly trial-and-error, while opening the door to more targeted, personalized treatments. As AI reshapes the pharmaceutical landscape, it holds the promise of delivering safer, more effective medicines. Revolutionizing Pharmaceuticals With AI-Driven Drug Discovery, Design, and Development explores the advancements of algorithms and computing technology in pharmacology. This book examines how the integration of AI technology with pharmaceuticals accelerates the process of drug discovery, design, and development. Covering topics such as drug toxicity, machine learning, and nutrition systems, this book is an excellent resource for pharmacologists, medical and healthcare professionals, researchers, academicians, and scientists.

Full Product Details

9798337352589

Table of Contents

Reviews

Author Information

Jen-Tsung Chen is a professor of cell biology at the National University of Kaohsiung in Taiwan. He also teaches genomics, proteomics, plant physiology, and plant biotechnology. Dr. Chen's research interests include bioactive compounds, chromatography techniques, plant molecular biology, plant biotechnology, bioinformatics, and systems pharmacology. He is an active editor of academic books and journals to advance the exploration of multidisciplinary knowledge involving plant physiology, plant biotechnology, nanotechnology, ethnopharmacology, systems biology, and drug discovery. He serves as an editorial board member and a guest editor in several reputed journals. Dr. Chen published books in collaboration with international publishers on diverse topics such as drug discovery, herbal medicine, medicinal biotechnology, nanotechnology, bioengineering, plant functional genomics, plant speed breeding, CRISPR-based plant genome editing, and artificial intelligence. In 2023 and 2024, Elsevier and Stanford University recognized Dr. Chen as one of the ""World's Top 2% Scientists"".

Tab Content 6

Countries Available